1 |
ZHANG L, WU H, LU D, et al. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus[J]. Oncogene, 2013, 32(46): 5347-5358.
|
2 |
LIANG L, JIANG Y, CHEN J S, et al. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases[J]. Hum Pathol, 2016, 57: 1-6.
|
3 |
LIU C L, ZANG X X, HUANG H, et al. The expression of B7-H3 and B7-H4 in human gallbladder carcinoma and their clinical implications[J]. Eur Rev Med Pharmacol Sci, 2016, 20(21): 4466-4473.
|
4 |
KRAMBECK A E, THOMPSON R H, DONG H D, et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival[J]. Proc Natl Acad Sci U S A, 2006, 103(27): 10391-10396.
|
5 |
HONG B, QIAN Y, ZHANG H, et al. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma[J]. World J Gastroenterol, 2016, 22(18):4538-4546.
|
6 |
JIANG J T, ZHU Y B, WU C P, et al. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer[J]. Cancer Immunol Immunother, 2010, 59(11): 1707-1714.
|
7 |
LIU W H, CHEN Y Y, ZHU S X, et al. B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms[J]. Oncol Lett, 2014, 8(6): 2527-2534.
|
8 |
ZHU J, CHU B F, YANG Y P, et al. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer[J]. Asian Pac J Cancer Prev, 2013, 14(5): 3011-3015.
|
9 |
ZHAO L W, LI C, ZHANG R L, et al. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration[J]. Acta Histochem, 2014, 116(7): 1163-1168.
|
10 |
WANG P, LI C, ZHANG F, et al. Clinical value of combined determination of serum B7-H4 with carcinoembryonic antigen, osteopontin, or tissue polypeptide-specific antigen for the diagnosis of colorectal cancer[J]. Dis Markers, 2018, 2018: 4310790.
|
11 |
ICHIKAWA M, CHEN L P. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms[J]. Front Biosci, 2005, 10: 2856-2860.
|
12 |
QIAN Y, SHEN L, CHENG L F, et al. B7-H4 expression in various tumors determined using a novel developed monoclonal antibody[J]. Clin Exp Med, 2011, 11(3): 163-170.
|
13 |
WANG W, XU C H, WANG Y C, et al. Prognostic values of B7-H4 in non-small cell lung cancer[J]. Biomarkers, 2016: 1-16.
|
14 |
SIMON I, LIU Y, KRALL K L, et al. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer[J]. Gynecol Oncol, 2007, 106(1): 112-118.
|
15 |
ZHANG C, LI Y M, WANG Y. Diagnostic value of serum B7-H4 for hepatocellular carcinoma[J]. J Surg Res, 2015, 197(2): 301-306.
|
16 |
DANIAL N N, KORSMEYER S J. Cell death: critical control points[J]. Cell, 2004, 116(2): 205-219.
|
17 |
SONG Z, FAN T J. Tetracaine induces apoptosis through a mitochondrion-dependent pathway in human corneal stromal cells in vitro [J]. Cutan Ocul Toxicol, 2018, 37 (4):350-358.
|
18 |
MASSAGUÉ J, OBENAUF A C. Metastatic colonization by circulating tumour cells[J]. Nature, 2016, 529(7586): 298-306.
|
19 |
GIALELI C, THEOCHARIS A D, KARAMANOS N K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting[J]. FEBS J, 2011, 278(1): 16-27.
|
20 |
ARAÚJO R F, LIRA G A, VILAÇA J A, et al. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer[J]. Pathol Res Pract, 2015, 211(1): 71-77.
|
21 |
RANOGAJEC I, JAKIĆ-RAZUMOVIĆ J, PUZOVIĆ V, et al. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients[J]. Med Oncol, 2012, 29(2): 561-569.
|
22 |
WALDMANN T A, CHEN J. Disorders of the JAK/STAT pathway in T cell lymphoma pathogenesis: implications for immunotherapy[J]. Annu Rev Immunol, 2017, 35: 533-550.
|
23 |
PITTS T M, NEWTON T P, BRADSHAW-PIERCE E L, et al. Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancer[J]. PLoS One, 2014, 9(11): e113037.
|
24 |
FRANCIPANE M G, LAGASSE E. mTOR pathway in colorectal cancer: an update[J]. Oncotarget, 2014, 5(1): 49-66.
|
25 |
JOHNSON S M, GULHATI P, RAMPY B A, et al. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer[J]. J Am Coll Surg, 2010, 210(5): 767-776.
|